MAPT and Alzheimer disease: Tau inhibits katanin in neurons [28, 41–43] and we have observed in fibroblasts that the Alzheimer's disease-related pseudo-hyperphosphorylated (PHP)-tau and FTDP-17-derived mutant tau have a reduced capacity for this inhibition [44].